未知生产厂商
Parkinson's disease results from degeneration of the dopaminergic cells in the substantia nigra. Several dopamine receptor agonists have been used as antiparkinsonian therapy. Sumanirole is a dopamine receptor agonist with a high selectivity for the D2 receptor subtype over the other closely related D3 and D4 receptor subtypes.
Investigated for use/treatment in parkinson's disease.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
